A phase III trial comparing CHOP to PMitCEBO with or without G-CSF in patients aged 60 plus with aggressive non-Hodgkin's lymphoma

The management of older patients with aggressive non-Hodgkin's lymphoma presents a challenge to the physician. Age is a poor prognostic indicator, due to reduced ability to tolerate and maintain dose-intensive chemotherapy. Generally, older patients demonstrate a lower response rate, reduced su...

Descripción completa

Detalles Bibliográficos
Autores principales: Burton, C, Linch, D, Hoskin, P, Milligan, D, Dyer, M J S, Hancock, B, Mouncey, P, Smith, P, Qian, W, MacLennan, K, Jack, A, Webb, A, Cunningham, D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2006
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3216418/
https://www.ncbi.nlm.nih.gov/pubmed/16508640
http://dx.doi.org/10.1038/sj.bjc.6602975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3216418/
https://www.ncbi.nlm.nih.gov/pubmed/16508640
http://dx.doi.org/10.1038/sj.bjc.6602975

Ejemplares similares